Practical experience with FTrees searching

webinar

Tue, 11 Dec 2018, 16:00 CET (Berlin)

Dr. Andrew Anighoro, Senior Scientist, Evotec

Practical experience with FTrees searching

Searching by similarity is a basic necessity in pharmaceutical research and myriad of different approaches are available. In this webinar we take a closer look at the FTrees method. It is based on a topological pharmacophore description of the molecule (the Feature Tree) and an algorithm that calculates the similarity based on an optimal mapping of two Feature Trees. We quickly introduce the science and technology at work behind the scenes and then focus on the discussion of two example applications in the context of drug discovery.

The first example will cover the results obtained in several retrospective virtual screenings (VS) carried out by applying FTrees and standard 2D fingerprint-based similarity calculations. The aim of this study was to assess the potential of these methods to prioritise active compounds. In a follow up study, we then tested a new option in FTrees, namely the ability to nominate more and less important features on a query molecule, on the basis of the same benchmark data.

In the second example, a comparable analysis was performed in a prospective VS of a challenging drug discovery project. While both methods unfortunately failed to identify new active compounds, there was very limited overlap in the compounds selected by FTrees and 2D-fingeprints, suggesting that FTrees and 2D fingerprints may be considered as complementary approaches to define compound similarity.

Current news

category
Events
Recordings of the BioSolveIT Day 2025 Available
October 15, 2025 13:39 CEST
Missed BioSolveIT Day 2025? The recordings from BioSolveIT Day 2025 are now live! Packed with practical insights for medicinal and computational chemists, the sessions showcase how SeeSAR, infiniSee, Chemical Space Docking®, and CoLibri accelerate real-world discovery, from pocket-aware design and HYDE-guided decisions to trillion-scale, synthesizable chemical space exploration and in-house...
Read on
Enamine’s REAL Space September 2025 Update - Now 83 Billion!
September 23, 2025 10:31 CEST
The September 2025 update of Enamine’s REAL Space brings a new expansion, now featuring over 83 billion accessible, drug-like products, up from 76 billion in the previous release. Built from 172 curated reactions and 192,487 reagents and building blocks based on in-house knowledge, this version further enhances one of the...
Read on
WuXi’s GalaXi Space September 2025 – Expanded to 26 Billion Molecules!
September 17, 2025 10:03 CEST
The September 2025 update of WuXi LabNetwork’s GalaXi Space delivers a major expansion, now featuring over 25.8 billion synthesis-ready products. Built from 185 curated reactions and 30,877 high-quality building blocks, GalaXi is one of the largest tangible Chemical Spaces for modern drug discovery. This release broadens structural diversity with novel...
Read on